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Burden of disease resulting from lead
exposure at toxic waste sites in Argentina,
Mexico and Uruguay
Jack Caravanos1, Jonathan Carrelli2*, Russell Dowling2, Brian Pavilonis1, Bret Ericson2 and Richard Fuller2
Abstract
Background: Though lead contaminated waste sites have been widely researched in many high-income countries, their
prevalence and associated health outcomes have not been well documented in low- and middle-income countries.
Methods: Using the well-established health metric disability-adjusted life year (DALY) and an exposure assessment
method developed by Chatham-Stephens et al., we estimated the burden of disease resulting from exposure to lead at
toxic waste sites in three Latin American countries in 2012: Argentina, Mexico and Uruguay. Toxic waste sites identified
through Pure Earth’s Toxic Sites Identification Program (TSIP) were screened for lead in both biological and environmental
sample media. Estimates of cardiovascular disease incidence and other outcomes resulting from exposure to lead were
utilized to estimate DALYs for each population at risk.
Results: Approximately 316,703 persons in three countries were at risk of exposure to pollutants at 129 unique sites
identified through the TSIP database. Exposure to lead was estimated to result in between 51,432 and 115,042 DALYs,
depending on the weighting factor used. The estimated burden of disease caused by exposure to lead in this analysis
is comparable to that estimated for Parkinson’s disease and bladder cancer in these countries.
Conclusions: Lead continues to pose a significant public health risk in Argentina, Mexico, and Uruguay. The burden of
disease in these three countries is comparable with other widely recognized public health challenges. Knowledge of the
relatively high number of DALYs associated with lead exposure may be used to generate support and funding for the
remediation of toxic waste sites in these countries and others.
Keywords: Latin America, Burden of disease, Disability-adjusted life year, Chemical exposure, Toxic waste sites, Lead
poisoning
Background
Environmental exposure to pollution from hazardous
waste sites is an understudied contributor to the global
burden of disease [1]. Increasing industrial development,
urbanization and socioeconomic forces in Latin America
have contributed to an increase in environmental pollution
and the negative health effects resulting from exposure [2].
The disability-adjusted life year (DALY), which takes into
consideration the burden of disease resulting from illness,
injury and death, is a standard metric for estimating the
burden of disease resulting from exposure to environmental
toxicants, among other risk factors. A previous study by
Prüss-Ustün estimated that exposure to various chemicals
accounts for 5.7 % of total global DALYs and 8.3 % of global
deaths [3]. Another study estimated that 0.22 % of the total
estimated DALYs from all causes were attributed to pollut-
ants found at hazardous waste sites in India, Indonesia and
the Philippines [4].
It is estimated that 94 % of the burden of disease result-
ing from pollution falls on low- and middle-income coun-
tries as defined by the World Bank (LMICs) [5]. While
much of the developed world has made significant pro-
gress in eliminating the burden of disease caused by infec-
tious diseases, chronic illnesses increasingly affect a great
population [6]. Chronic illnesses, such as cardiovascular
disease, neurodevelopmental disorders and cancers are
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often linked to environmental exposures, yet enumerating
the specific burden of disease impacts from environmental
agents has proven difficult [7].
There is a need to better understand linkages between
contaminated sites and health outcomes in LMICs. Accur-
ate DALY models enumerated by contaminant, exposure
pathway, and affected population offer one possible ap-
proach. Summary measures may then be used during the
policymaking process to discern what public health
threats are of greatest concern and what policies are
most effective [8].
Heavy metals are still widely used in the production of
consumer goods [9]. In LMICs, inadequate regulation,
informality of many industries, poor surveillance, and
improper disposal of contaminants can result in danger-
ous exposures to nearby residents. Of particular concern
is lead (Pb). Although the risk of disease resulting from
exposure to lead is widely known, widespread use con-
tinues [10]. For example, lead is still used to glaze arti-
sanal ceramics despite the availability of less hazardous
alternatives. Elevated levels of lead in water and soil can
then expose adjacent populations, putting them at risk
of a number of adverse health outcomes.
Lead is a bluish-gray metal with many desirable qualities
such as electrical conductivity, malleability, density and
low-corrosivity and has been mined for centuries, often
combined with other metals to form alloys [10]. Anthropo-
genic sources of lead in the environment include smelting,
mining, used lead-acid battery (ULAB) recycling and cer-
amic pottery making [11, 12]. Compared to adults, children
absorb more lead and are therefore more vulnerable to the
adverse effects of lead. Early childhood exposure to lead
can be particularly harmful and has been shown to cause
behavioral problems in adolescence [13], IQ decrements
[14], cognitive impairment [15], and decreased visuospatial
skills [16]. Adults are typically exposed occupationally and
experience higher rates of hypertension than the general
population, leading to an increased incidence of cardiovas-
cular disease [17]. Low-level chronic exposure to lead may
result in low sperm count or impotence in males. In fe-
males, it can result in miscarriage and low birth weight of
offspring, as lead may be transferred through the placenta
to the fetus [16].
This research aims to accurately quantify the burden of
disease caused by lead found at toxic waste sites in
Argentina, Mexico and Uruguay. Earlier work done by
Caravanos et al. described the pediatric burden of Pb and
other heavy metals exposure in several Asian countries
[18]. This analysis seeks to elucidate the impact of lead on
human health in a different part of the world. The resulting
analysis aims to provide a basis for public health interven-
tion and environmental remediation at both the national
and regional level, as well as to inform strategies for con-
tinued site investigation of contaminated sites.
Methods
Site identification
Environmental and biological exposure data were obtained
from the Toxic Sites Identification Program (TSIP). The
TSIP is an effort implemented by the New York-based
non-profit Pure Earth (formerly Blacksmith Institute) and
has been supported by the United Nations Industrial Devel-
opment Organization (UNIDO), the European Commission
(EC), the World Bank, and the Asian Development Bank,
among others. The TSIP identifies active and abandoned
hazardous waste sites resulting from both formal and infor-
mal industrial activities in LMICs. Informal activities in-
clude but are not limited to electronic waste or scrap metal
recycling, used lead-acid battery recycling, small-scale gold
mining, leather tanning, and ceramic pottery making. There
are currently more than 3200 sites in the TSIP database, of
which 2300 have been visited onsite by a trained TSIP
investigator. A majority of the locations screened are aban-
doned (legacy) sites, including former tanneries and small-
scale artisanal sites such as ULAB recycling and artisanal
gold mining [4]. The TSIP does not include exposure data
from non-point sources such as vehicle traffic or sewage
contaminated water. As part of a TSIP investigation, a “key
pollutant” is identified and analyzed. Heavy metals are the
most commonly occurring key pollutant, with ingestion of
contaminated soils being the most commonly occurring
route of exposure listed in the TSIP database [19].
Three countries were utilized for this analysis: Argentina,
Mexico and Uruguay (Table 1). These countries were
chosen primarily on the basis of the availability of data after
the inclusion and exclusion criteria outlined below were
applied to the raw data. Sites that did not meet all five cri-
teria were not included in the analysis. No additional data
collection was conducted for this paper.
In order for a hazardous waste site to be included in the
analysis, five criteria must have been met: there must be a
credible pathway of human exposure; a biological or
Table 1 Country demographicsa
Country Total population
(in millions)
Population density
(inhabitants per km2)
GDP per capita
(USD)
Infant mortality
(per 1,000)
Life Expectancy
(years)
Argentina 41.45 14.4 22375 11 76.01
Mexico 122.3 57 10174 11 77.14
Uruguay 3.4 18.9 16996 9 76.91
aThe World Bank, 2014
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environmental sample had to be present; a population at
risk had to be specified; the location of the site was repre-
sented by GPS coordinates; and a description of the activ-
ities leading to contamination were outlined. The TSIP
database contained 23 site surveys in Argentina, 62 in
Mexico, and 44 in Uruguay that met the inclusion criteria
of this study. A total of 129 sites analyzed with data from
164 environmental lead samples and 75 blood lead level
measurements were included in the analysis. It should be
noted that while numerous sites contain both blood lead
and soil lead data, there are also many sites that contain
data from only one sample medium.
Exposure assessment
Local site investigators in the field collected environmen-
tal samples with the guidance of a sampling protocol pro-
vided by Pure Earth. Biological samples were made
available through collections by local health offices and
ministries. An independent ethics committee determined
that the study was exempt from further review as catego-
rized by the US Department of Health and Human
Services Policy for Protection of Human Research Sub-
jects. Lead concentrations in soil were measured in the
field using an Innov-X handheld X-ray fluorescence (XRF)
spectrometer (4000 Alpha Series; Auburndale/Newton,
MA). XRFs are calibrated accordingly prior to soil sample
analysis. When an XRF was unavailable, samples were sent
to a local laboratory for analysis. Exposure pathways in
the analysis included inhalation of dust and ingestion of
lead contaminated soil. All Pb exposure was estimated
through blood lead levels (BLLs) (n = 75) or soil concen-
trations (n = 164). In areas suspected of lead contamin-
ation, BLLs were prioritized, as they are the standard
marker of human exposure [20]. The U.S. Centers for
Disease Control and Prevention (CDC) sets an upper limit
of 5 μg/dL for children under the age of 6 years [21].
While the “actionable” reference BLL was lowered from
10 μg/dL to 5 μg/dL in 2012 by the CDC, 10 μg/dL is still
the standard reference BLL in most countries [22]. When
a site contained less than 5 biological samples, environ-
mental sample data such as lead in soil was used to calcu-
late burden of disease estimates.
Population estimates and age distribution
An age distribution of the population must be used when
calculating the burden of disease. It has been well docu-
mented that children are more susceptible to negative
health effects caused by exposure to toxic pollution than
adults [23, 24]. Hazardous chemicals are ingested and in-
haled into the body of children at a much higher rate than
in adults. Furthermore, toxicants can affect children during
critical windows of development when children’s bodies
and neurological function are most at risk [24]. Children
also engage in more high-risk behaviors when compared to
adults—they are lower to the ground and tend to have
more unwashed hand to mouth contact [18]. As age
distribution was not recorded as part of TSIP protocol,
province-specific age distributions from the respective
countries’ census institutions were used in disease esti-
mates [4, 25–28].
A local country specific investigator develops a Concep-
tual Site Model (CSM) for each site assessed as part of the
TSIP. The CSM allows the investigator to determine key
sources, migration routes, and chemical exposure pathways.
Additionally the investigator using the CSM determines the
estimated “population at risk.” A population count is then
generated from residences and communities adjacent to all
sources of exposure using reported housing densities (num-
ber of persons per household). High-resolution aerial im-
agery is also used to confirm population estimates by
reviewing the number of people residing within the affected
area (defined as having a radius of 50 m). For the purpose
of this analysis, population at risk estimates were reviewed
against similar sites in the TSIP database.
Risk estimates
Risk was calculated for non-carcinogenic health endpoints
based on lead toxicity [4]. Disease incidence and burden
for lead were calculated separately using the USEPA’s Inte-
grated Exposure, Uptake and Biokinetic (IEUBK) model
and tools developed by the World Health Organization
(WHO) [29, 30]. The IEUBK model is used to estimate
BLLs in children resulting from Pb exposure via soil, air,
water, food, and maternal blood lead [20].
The IEUBK Model is a validated tool that estimates
the geometric mean of BLL from exposure to multiple
sources of lead. However, for this analysis we limited the
model to soil lead exposure from each site. We entered
these values into the model and calculated mean BLLs
for each site. Exposure intakes for air lead levels, dietary
intake of lead, water lead levels, maternal BLL and alter-
nate sources of lead were set to “zero” so that the result-
ant estimated BLL is attributable solely to soil lead
exposure. The IEUBK EPA model is specific to children
so in estimating adult blood lead levels we applied the
USEPA’s Adult Lead Methodology (ALM) exposure
model [31]. As with IEUBK, only lead in soil inputs were
used in the model with all other sources set to “zero”.
Incidence of disease
Blood lead levels from exposure to environmental soil and
dust lead levels were estimated using the US EPA’s IEUBK
model. Exposure estimates were calibrated upward to ac-
count for the typically dustier conditions of low-income
areas in LMICs. Values used elsewhere for indigenous
populations were utilized here [32–34]. DALYs resulting
from measured blood lead level samples and estimated
blood lead levels were calculated separately using disease
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incidence and spreadsheets created by the WHO [35].
Using these spreadsheets, both incidence of mild mental
retardation (MMR) in children and cardiovascular disease
in adults were calculated for lead [4].
Burden of disease calculation
The DALY is a time-based measure of health that combines
indices of years lived with disability (YLD) and years of life
lost (YLL). YLD and YLL were calculated based on expos-
ure estimates collected in the field. YLD is the product of
years lived with a disability and a specific disability weight
(DW). A DW is scaled between zero and one, with zero
representing perfect health and one representing the worst
possible state of health (equivalent to death) [36]. For
example, mild mental retardation attributable to lead ex-
posure has a DW of 0.36 while metastatic lung cancer has
a DW of 0.75 [37].
In order to calculate YLD the relevant type of non-cancer
health effect was matched with the corresponding DW (i.e.,
neurological effects) [4]. Years lived with disability resulted
from an estimation of life expectancy multiplied by the
appropriate disability weight for the exposure scenario [4].
Years of life lost were calculated only for exposure to car-
cinogens; as a result, lead exposure did not contribute to
YLL [4]. This is the standard method for calculating lead
induced MMR, as lead exposure very rarely results in
death.
DALYs resulting from cardiovascular disease were trans-
formed into percentages to show a distribution across age
groups for each country using the WHO’s Global Health
Estimates Summary Tables [29]. The percentage of DALYs
attributable to ischemic heart disease, cerebrovascular dis-
ease, hypertensive disease and all other cardiac diseases
were calculated for each country individually. By using
BLLs and this percentage of DALYs attributable to cardio-
vascular disease in a WHO spreadsheet, DALYs attribut-
able to lead exposure were calculated [4, 38].
Age weighting factors, along with a discount rate, were
applied to both YLD and YLL to provide a range of DALY
estimates. Age weights are applied to burden of disease esti-
mates in an effort to reflect the relative population distribu-
tion, while discount rates are often employed in burden of
disease studies to account for intergenerational differences
in health benefits reaped from public health interventions
and a decrease disease incidence [4, 39]. Both the age
weights and discount rates are signified in the notation
DALYs(r,K), where r is the discount rate and K is the age
weight. Results expressed as DALYs(3,1) represent a 3 %
discount rate (recommended by the U.S. Panel on Cost-
Effectiveness in Health and Medicine and utilized by the
WHO) and full age weighting, while those expressed as
DALYs(3,0) include only the discount rate [40]. DALYs(0,0)
represent a burden of disease estimate without weighting.
Sensitivity analysis
A range of estimates was also created through a sensitiv-
ity analysis by adjusting the size of the population at
risk. This analysis calculates the effect of lead on a popu-
lation plus and minus 25 % of the current estimate to
account for possible fluctuations in the population.
Results
Exposure data were collected from a total of 129 hazard-
ous waste sites distributed across Argentina (n = 23),
Mexico (n = 62), and Uruguay (n = 44). The geographical
distributions of these sites are shown in Figs. 1 and 2. The
estimated population at risk of exposure was 316,703 indi-
viduals (mean = 2455; median = 250 per site), which is
approximately 0.19 % of the total population of all three
countries. Of this population, it was estimated that 80,021
were women of childbearing age (15–49 years of age), and
122,084 individuals were younger than 18 years of age
(Table 2). Of the exposed population, the proportion of
women of childbearing age was relatively equal across the
three countries.
Biological (n = 75) and environmental measurements
(n = 164) were used to calculate risk. An arithmetic
mean was calculated for environmental or biological
samples at each site, unless the site’s test results differed
more than one order of magnitude. In these cases, a
geometric mean was used as outlined in the sampling
protocol provided by Pure Earth. Mean blood lead levels
(BLLs) in Mexico (n = 56) and Uruguay (n = 19) were
found to be 19.63 μg/dL and 13.3 μg/dL respectively
(Table 3). Lead concentrations in soil (n = 164) were the
highest and relatively uniform across the three countries
(Table 4). Mean soil lead concentrations in Mexico
(2748 mg/kg) were the greatest, followed by Uruguay
(2559 mg/kg) and Argentina (1730 mg/kg).
BLLs were used to estimate DALYs in exposed popula-
tions in Mexico (79,196) and Uruguay (5859). As BLLs
were not collected in Argentina, DALYs based on that
exposure measurement could not be calculated. Elevated
BLLs were responsible for 23,421 DALYs in Mexico,
representing 52 % of the disease burden estimated as a
result of lead exposure. Elevated BLLs were responsible
for 942 DALYs in Uruguay, representing 46 % of the
total disease burden for lead exposure.
An estimated 27,069 DALYs resulted from exposure to
lead in soil. Combined with an estimated 24,363 DALYs
based on BLL, overall lead exposure accounted for a total
of 51,432 YLDs. The estimated population at risk for expos-
ure to lead was 316,703, largely derived in sites from
Mexico (189,593) and Argentina (112,208). An estimated
0.31 DALYs(3,1) per person resulted from lead exposure at
129 unique toxic waste sites screened in Argentina, Mexico
and Uruguay.
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Without age weights, 45,492 DALYs (3,0) resulted, while
removing both age weight and discount rate resulted in
115,042 DALYs (0,0). To present a range of estimates, ex-
posed population was adjusted to 25 % less than the
original estimate, resulting in 38,581 DALYs(3,1). If the
exposed population was adjusted to 25 % greater than the
original estimate, the resulting DALYs(3,1) were 64,266. A
remediation scenario where lead levels were adjusted
below international standards resulted in 7,078 DALYs(3,1)
(Table 5).
Discussion
This study sought to characterize the number of years lost
due to illness, disability, or early death from lead exposure
in Argentina, Mexico, and Uruguay. Environmental levels
of lead were characterized in those countries and DALYs
were calculated based on estimated exposure. In total, an
estimated 51,432 DALYs from a total of 316,703 people
exposed to lead at 129 toxic waste sites were located
throughout the study region. This translates to approxi-
mately .31 DALYs(3,1) per person. The estimated burden of
disease as a result of exposure to lead was approximately
0.12 % of DALYs for all causes as estimated by the WHO
in Argentina, Mexico and Uruguay [29].
By quantifying disease burden from lead pollution
through a DALY-based method developed by Chatham-
Stephens et al., comparisons can be made to other public
health threats and illnesses. The modeled burden of disease
estimated for exposure to lead at screened sites is compar-
able to the burden resulting from more widely recognized
public health issues such as Parkinson’s disease (52,800
DALYs), Acute Hepatitis B and C combined (43,300) and
bladder cancer (59,500 DALYs) in the three countries ana-
lyzed [28, 40]. The estimated burden of disease due to lead
exposure is also greater than estimates for all childhood-
cluster diseases including pertussis, diphtheria, measles,
and tetanus (9,100 DALYs) and multiple sclerosis (27,500
DALYs) [29]. A comparison of DALYs from lead exposure
and other health outcomes in Argentina, Mexico and
Uruguay can be seen in Table 6, though it must be reiter-
ated that DALYs from lead exposure are estimated rather
than empirical.
The ingestion and inhalation of lead contaminated soil
and dust was the main exposure pathway in the data an-
alyzed. Biomarkers (blood lead levels) were used in the
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Fig. 1 Geographical distribution of TSIP sites in Mexico with DALYs resulting from lead exposure
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calculation of disease burden for lead exposure in Mexico
and Uruguay, accounting for 47.4 % of the DALYs esti-
mated in those countries.
Mexico is the fourth-largest producer of lead worldwide,
with 222,000 metric tons generated in 2012 and a continu-
ally increasing output [41]. Sites in Mexico included in the
lead exposure analysis were currently or previously involved
with production of earthenware with leaded glaze (n = 31),
mining operations (n = 22), smelting activities (n = 3),
used lead-acid battery recycling (n = 1) and manufac-
turing (n = 5).
If BLLs were adjusted to below the “actionable” limit
recommended by the CDC (5 ug/dL), an estimated 24,281
DALYs in Mexico (23,342 DALYs) and Uruguay (939
DALYs) could be eliminated. Such interventions include
the introduction of lead-free glaze in ceramic ware, legisla-
tion to regulate battery-recycling, reduction of lead dust in
homes, education about the health effects resulting from
Pb exposure, as well as continued monitoring of BLLs. In
comparison with the initial DALYs(3,1) estimate, 44,354
DALYs(3,1) could be eliminated if these sites were reme-
diated. Despite producing lead in smaller quantities, ex-
posure contributed significantly to disease burden in both
Argentina (83,700 metric tons from primary and second-
ary lead smelting in 2013, 4,061 DALYs(3,1)) and Uruguay
(no lead production data available, 2,051 DALYs(3,1)) [42].
A previous burden of disease study by Chatham-
Stephens et al. found 54,432 DALYs attributable to lead
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Fig. 2 Geographical distribution of TSIP sites in Argentina and Uruguay with DALYs resulting from lead exposure
Table 2 Exposed population by age and childbearing status
Country Total Exposed Population
(Population)
Women of Childbearing Age -
15–49 years old (Population)
All Genders <18
Years old (Population)
Remaining Age
Groups (Population)
Argentina 112208 27852 36659 47697
Mexico 189593 48770 80904 59919
Uruguay 14902 3399 4521 6982
Total 316703 80021 122084 114598
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exposure in India (n = 24), 78,982 DALYs in Indonesia
(n = 28) and 394,084 DALYs in the Philippines (n = 27).
While these estimates are larger than the estimated
45,321 DALYs attributable to lead-contaminated sites in
Mexico (n = 62), an estimated 0.41 DALYs per person
resulted from lead exposure at these sites, higher than
previous estimates for India (0.21 DALYs per person),
Indonesia (0.21 DALYs per person) and the Philippines
(0.30 DALYs per person). In the same study, 0.10 DALYs
per person were estimated for exposure to eight chemicals
in India, Indonesia, and the Philippines (mean population
at risk of exposure per site = 23,079) [4], while an estimated
.31 DALYs(3,1) per person occurred due to exposure to lead
in Argentina, Mexico and Uruguay (mean population at
risk of exposure per site = 2455). This higher average DALY
per person was likely a result of a smaller population at risk
and higher lead concentrations found in the three countries
in this review.
A number of limitations for the calculation of disease
burden should be noted. One such limitation has to do
with extrapolation from a limited number of samples.
The TSIP assessment process relies on minimal environ-
mental sampling, composed of targeted and composited
samples. The methodology was developed for screening
purposes and is insufficient to fully characterize health
risks at a site. As a result, the estimates here are neces-
sarily indicative rather than definitive in nature.
A second significant limitation has to do with the lim-
ited number of sites captured by the TSIP. The number
utilized here, 129, is very likely a significant undercount
of the total number. Future efforts might endeavor to
document additional sites or develop a robust method-
ology for modeling what that number might be.
A final limitation is the singular focus on lead. TSIP site
investigators collect data for a range of pollutants includ-
ing arsenic, hexavalent chromium, mercury, pesticides and
particulate matter contributing to air pollution. However,
these analyzed samples were too few in number to gener-
ate an accurate burden of disease estimate. In order for
this exercise to be repeated with other pollutants, both
data collection and site identification need to be improved.
The use of mercury in artisanal small-scale gold mining
(ASGM), for example, is a known threat to public health
in Latin America, and future site investigations must con-
tinue to identify sites of mercury exposure [43]. As the
analysis was solely focused on exposure to lead, it is likely
that the burden of disease resulting from exposure to toxic
pollution is largely underestimated.
Conclusion
Intervention and remediation programs must focus on
lead-contaminated sites in Argentina, Mexico and Uruguay
as exposure to lead continues to contribute a significant
disease burden for the population in these countries. An
estimated 316,703 persons are subject to lead exposure at
screened sites in these countries, resulting in 51,432
DALYs(3,1). However, site investigations and efforts to
estimate the burden of disease caused by pollution must
continue to incorporate threats from exposure to mercury,
arsenic, hexavalent chromium, pesticides, air pollution and
Table 3 Blood Lead Level (BLL) Data by Country
Country N Mean (μg/dL) S.D. (μg/dL) Range
Argentina N/A N/A N/A N/A
Mexico 56 19.63 9.9 7.7–41.1
Uruguay 19 13.3 9.21 5.1–47.35
Table 4 Environmental Lead Sample Data
Argentina Mexico Uruguay
N Meana N Meana N Meana
Soil Samples (mg/kg) 48 1730 59 2748 57 2559
aValue shown is either the mean or single measurement
Table 5 Sensitivity analysis estimates
Scenario Total DALYs
Primary estimate of screened sites 51432 DALYs(3,1)
Estimate without age weights 45492 DALYs(3,0)
Estimate without age weights or discount rate 115042 DALYs(0,0)
Remediation scenario 7078 DALYs (3,1)
If actual exposed population is 25 % less 38581 DALYs(3,1)
If actual exposed population is 25 % greater 64266 DALYs(3,1)
Table 6 DALY Comparisons by Health Outcome
Selected Outcomes and Exposures Total DALYs
Leishmaniasis 2800
Childhood-cluster Diseasesa 9100
Multiple Sclerosis 27500
Chlamydia 39100
Acute Hepatitis B and C 43300
Lead Exposure (Modeled) 51432
Parkinson’s Disease 52800
Bladder Cancer 59500
Melanoma and Skin Cancers 63800
Tuberculosis 141500
Asthma 295700
Diarrheal Disease 375100
HIV 469100
Respiratory Infectionsb 153500
Diabetes Mellitus 3102600
DALYs 2012 estimates (WHO, 2014)
Bold data are based on our modeled estimate using a method developed by
Chatham-Stephens et al
aChildhood-cluster diseases include pertussis, diphtheria, measles, and tetanus
bRespiratory infections includes lower respiratory infections, upper respiratory
infections, and otitis media
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other contaminants. Future studies should attempt to ex-
trapolate these estimates to unscreened sites in an effort to
approximate a more accurate burden of disease. This larger
estimate is likely to be comparable with the burden of
disease resulting from myriad chronic illnesses, and may be
used as a tool to generate support and funding for the
remediation of toxic waste sites in these countries and
others. While the three countries of study have protocols
in place to monitor children’s BLLs and reduce lead ex-
posure, programs to regulate ULAB recycling exist only in
Argentina, and regulations limiting the content of residen-
tial paint exist in only Argentina and Uruguay. Efforts to
reduce the burden of disease resulting from lead exposure
such as these and others must be implemented in all
countries to adequately reduce the burden of disease from
lead exposure.
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